{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T10:32:56Z","timestamp":1782642776789,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council\u00a0of\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bioorg.2019.103022","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T11:06:34Z","timestamp":1559300794000},"page":"103022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction"],"prefix":"10.1016","volume":"89","author":[{"given":"G. Lakshma","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd. Ishaq","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinandan D.","family":"Hudwekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Nargotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil Manzoor","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Wazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurdarshan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram A.","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad Hussain","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghapal D.","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103022_b0005","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP Phosphodiesterase-5: target of Sildenafil","volume":"274","author":"Corbin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.103022_b0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejmech.2018.02.039","article-title":"Design and synthesis of furyl\/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors","volume":"150","author":"Zheng","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103022_b0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejmech.2018.03.005","article-title":"Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)- selective inhibitors for the treatment of Alzheimer's disease","volume":"150","author":"Rabal","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103022_b0020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ejmech.2017.03.091","article-title":"Synthesis and in vitro evaluation of new fluorinated quinoline derivatives with high affinity for PDE5: Towards the development of new PET neuroimaging probes","volume":"136","author":"Liu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103022_b0025","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrd2030","article-title":"Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond","volume":"5","author":"Ghofrani","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103022_b0030","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/cn3000907","article-title":"Phosphodiesterases as therapeutic targets for Alzheimer's disease","volume":"3","author":"Garcia-Osta","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103022_b0035","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1124\/mol.105.017608","article-title":"Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line","volume":"68N","author":"Wunder","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103022_b0040","doi-asserted-by":"crossref","first-page":"7946","DOI":"10.1021\/jm9015334","article-title":"Identification of a brain penetrant PDE9A inhibitor utilizing prospective design and chemical enablement as a rapid lead optimization strategy","volume":"52","author":"Verhoest","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103022_b0045","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.1021\/jm3007799","volume":"55","author":"Verhoest","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103022_b0050","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/0960-894X(96)00323-X","article-title":"Sildenafil (VIAGRA\u2122), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction","volume":"6","author":"Terrett","year":"1996","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103022_b0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1756287212470019","article-title":"Udenafil: efficacy and tolerability in the management of erectile dysfunction","volume":"5","author":"Kang","year":"2013","journal-title":"Ther. Adv. Urol."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103022_b0060","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1742-1241.2006.01049.x","article-title":"Comparison of phosphodiesterase type 5 (PDE5) inhibitors","volume":"60","author":"Wright","year":"2006","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bioorg.2019.103022_b0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.ijir.3901525","article-title":"Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?","volume":"19","author":"Doggrell","year":"2006","journal-title":"Int. J. Impot. Res."},{"issue":"9","key":"10.1016\/j.bioorg.2019.103022_h0070","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.bmc.2015.03.005","article-title":"Discovery of Novel Pyrazolopyrimidinone Analogs as Potent Inhibitors of Phosphodiesterase Type-5","volume":"23","author":"Sawant","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103022_h0075","unstructured":"S.D. Sawant, G.L. Reddy, M. Srinivas, S.S. Hussain, M.I. Dar, A. Nargotra, P. Mahajan, R.A. Vishwakarma, Pyrazolopyrimidinones for the treatment of impotence and process for the preparation thereof. (WO 2015\/114647 A1, 08\/2015)."},{"issue":"15","key":"10.1016\/j.bioorg.2019.103022_b0075","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1016\/j.bmcl.2007.05.064","article-title":"3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors","volume":"17","author":"Yoo","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"30","key":"10.1016\/j.bioorg.2019.103022_b0080","doi-asserted-by":"crossref","first-page":"21469","DOI":"10.1074\/jbc.M512527200","article-title":"Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2019.103022_b0085","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1021\/jm701400r","article-title":"Synthesis and pharmacological evaluations of sildenafil analogues for treatment of erectile dysfunction","volume":"51","author":"Flores Toque","year":"2008","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2019.103022_b0090","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/anie.201610957","article-title":"A PDE6\u03b4-KRas Inhibitor chemotype with up to seven H-bonds and picomolar affinity that prevents efficient inhibitor release by Arl2","volume":"56","author":"Martin-Gago","year":"2017","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2019.103022_b0095","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.juro.2012.03.115","article-title":"Avanafil, a potent and highly selective phosphodiesterase-5 inhibitor for erectile dysfunction","volume":"188","author":"Kotera","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.bioorg.2019.103022_b0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0024-3205(98)00158-1","article-title":"Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells","volume":"62","author":"Moreland","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2019.103022_b0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.ijir.3900703","article-title":"A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection","volume":"13","author":"Bischoff","year":"2001","journal-title":"Int. J. Impot. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103022_b0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aid. Mol. Des."},{"issue":"7","key":"10.1016\/j.bioorg.2019.103022_b0115","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem."},{"key":"10.1016\/j.bioorg.2019.103022_b0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.yrtph.2017.10.033","article-title":"Pharmacokinetics, pharmacodynamics and safety profiling of IS01957, a preclinical candidate possessing dual activity against inflammation and nociception","volume":"91","author":"Sharma","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."}],"updated-by":[{"DOI":"10.1016\/j.bioorg.2019.103257","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000}}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819302226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819302226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:49:42Z","timestamp":1758613782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819302226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":25,"alternative-id":["S0045206819302226"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103022","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bioorg.2019.103257","asserted-by":"object"}]},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103022"}}